OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
Shohei Shinozaki, Asuka Watanabe, Masahiro Kimata, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 189-205
Open Access | Times Cited: 7
Shohei Shinozaki, Asuka Watanabe, Masahiro Kimata, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 189-205
Open Access | Times Cited: 7
Showing 7 citing articles:
Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients
Andrea Haddad, Ray Hachem, Mohamed Ben Moussa, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1055-1055
Open Access | Times Cited: 2
Andrea Haddad, Ray Hachem, Mohamed Ben Moussa, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1055-1055
Open Access | Times Cited: 2
Patient-Reported Adverse Events Among Elderly Patients Receiving Novel Oral COVID-19 Antivirals: A Nationwide Sampled Survey in Korea
H.A. Jung, Ji Yeon Park, Dongwon Yoon, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 41
Open Access | Times Cited: 1
H.A. Jung, Ji Yeon Park, Dongwon Yoon, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 41
Open Access | Times Cited: 1
Mass spectrometry‐based metabolomics reveals metabolism of molnupiravir may lead to metabolic disorders and hepatotoxicity
Jiahui Chen, Liqiong Chen, Bin Li, et al.
Biomedical Chromatography (2024) Vol. 38, Iss. 11
Closed Access
Jiahui Chen, Liqiong Chen, Bin Li, et al.
Biomedical Chromatography (2024) Vol. 38, Iss. 11
Closed Access
Selected Acute Safety Events Following the Use of Nirmatrelvir/Ritonavir or Molnupiravir for COVID ‐19: A Nationwide Cohort Study in South Korea
Ju Hwan Kim, Ahhyung Choi, Gihwan Bae, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access
Ju Hwan Kim, Ahhyung Choi, Gihwan Bae, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access
Assessment of pharmacokinetics and tolerability following single‐dose administration of molnupiravir in participants with hepatic or renal impairment
Kelly Duncan, Russ P. Carstens, Kristin L. Butterfield, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
Kelly Duncan, Russ P. Carstens, Kristin L. Butterfield, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
Molnupiravir for high-risk adults with COVID-19: target trial emulation in a Japanese cohort
Yuya Kimura, Hiroki Matsui, Sachiko Ono, et al.
Journal of Infection and Chemotherapy (2024) Vol. 31, Iss. 3, pp. 102587-102587
Closed Access
Yuya Kimura, Hiroki Matsui, Sachiko Ono, et al.
Journal of Infection and Chemotherapy (2024) Vol. 31, Iss. 3, pp. 102587-102587
Closed Access
